|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0029237,
umls-concept:C0029925,
umls-concept:C0035168,
umls-concept:C0085533,
umls-concept:C0087111,
umls-concept:C0239307,
umls-concept:C0332305,
umls-concept:C0543467,
umls-concept:C0919267
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-16
|
|
pubmed:abstractText |
All randomized trials of adjuvant chemotherapy for early-stage ovarian cancer have lacked the statistical power to show a difference in the effect on survival between adjuvant chemotherapy and no adjuvant chemotherapy. They have also not taken into account the adequacy of surgical staging. We performed a prospective unblinded, randomized phase III trial to test the efficacy of adjuvant chemotherapy in patients with early-stage ovarian cancer, with emphasis on the extent of surgical staging.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
pubmed-author:BolisGiorgioG,
pubmed-author:CoensCorneelC,
pubmed-author:EORTC-ACTION collaborators. European Organisation for Research and...,
pubmed-author:FranchiMassimoM,
pubmed-author:GiurgeaLiviaL,
pubmed-author:MadronalCaterinaC,
pubmed-author:MangioniConstantinoC,
pubmed-author:PecorelliSergioS,
pubmed-author:ScarfoneGiovannaG,
pubmed-author:TateoSaverioS,
pubmed-author:TimmersPetraP,
pubmed-author:TrimbosJ BaptistJB,
pubmed-author:VergoteIgnaceI,
pubmed-author:VermorkenJan BJB,
pubmed-author:ZanettaGerardoG
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
113-25
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12529344-Adult,
pubmed-meshheading:12529344-Aged,
pubmed-meshheading:12529344-Aged, 80 and over,
pubmed-meshheading:12529344-Antineoplastic Agents,
pubmed-meshheading:12529344-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12529344-Carboplatin,
pubmed-meshheading:12529344-Carcinoma,
pubmed-meshheading:12529344-Chemotherapy, Adjuvant,
pubmed-meshheading:12529344-Cisplatin,
pubmed-meshheading:12529344-Confidence Intervals,
pubmed-meshheading:12529344-Disease-Free Survival,
pubmed-meshheading:12529344-Europe,
pubmed-meshheading:12529344-Female,
pubmed-meshheading:12529344-Humans,
pubmed-meshheading:12529344-International Cooperation,
pubmed-meshheading:12529344-Middle Aged,
pubmed-meshheading:12529344-Neoplasm Staging,
pubmed-meshheading:12529344-Observation,
pubmed-meshheading:12529344-Odds Ratio,
pubmed-meshheading:12529344-Ovarian Neoplasms,
pubmed-meshheading:12529344-Prognosis,
pubmed-meshheading:12529344-Risk Factors,
pubmed-meshheading:12529344-Survival Analysis,
pubmed-meshheading:12529344-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
|
|
pubmed:affiliation |
Leiden University Medical Center, Leiden, The Netherlands. J.B.M.Z.Trimbos@lumc.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
